• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES COMMANDER DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES COMMANDER DELIVERY SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9610TF29
Device Problem Difficult or Delayed Positioning (1157)
Patient Problem Foreign Body In Patient (2687)
Event Date 01/04/2023
Event Type  Injury  
Event Description
Edwards received notification from our affiliate in germany.As reported, this was a case of an implant of a 29mm sapien 3 valve in aortic position by transfemoral approach.During the procedure, it was not possible to perform the gross valve alignment properly, the sapien 3 valve could not be pulled correctly onto the balloon because it was needed to apply a high force.Despite of the fact that the valve was not correctly aligned with the balloon, it was decided to deploy the valve as the patient's extreme cardiac unstable status (patient needed reanimation).When deploying the valve, it jumped upwards and the outflow was only opened.Therefore, the valve could not be retrieved at this point and it was decided to deploy it in the descending aorta.No difficulties were found during withdraw the delivery system from the patient after valve deployment.Due to the unstable overall situation and poor condition of the patient, a second sapien 3 kit was not used, the patient had to be opened and received a bioprosthesis.
 
Manufacturer Narrative
The investigation is in progress, a supplemental report will be submitted.
 
Manufacturer Narrative
The device was not returned for evaluation as it was discarded.Therefore, a no product return engineering evaluation was performed.A review of edwards lifesciences risk management documentation was performed for this case.The reported event is an anticipated risk of the transcatheter heart valve procedure, additional assessment of the failure mode is not required at this time.The complaints gross and fine adjustment valve alignment difficulty was confirmed based on evaluation of provided imagery.However, a manufacturing non-conformance was unable to be determined.Additionally, a review of the dhr and lot history did not provide any indication that a manufacturing non-conformance would have contributed to the complaint.A review of the ifu and training manuals revealed no deficiencies.As reported, ''during procedure, it was not possible to perform the gross valve alignment properly, the sapien 3 valve could not be pulled correctly onto the balloon because it was needed to apply a high force.'' while no imagery of the patient anatomy was provided, it is possible that valve alignment was conducted in a non-straight section.If valve alignment was performed in a tortuous (non-straight section) vasculature, this can cause the valve to become unseated (non-coaxial placement of valve in relation to the flex tip) and ''dive'' into the flex tip.If the thv is unseated from the flex tip during alignment, it can result in higher-than-normal alignment forces creating high tension in the system which can consequentially lead to the observed valve alignment difficulties.Under simulated conditions (simulated tortuous anatomy), a previously performed engineering study was able to recreate high valve alignment forces.The study revealed that performing valve alignment in a curvature appears to increase the possibility of ''diving'' (thv become unseated from the flex tip), which in turn increases valve alignment force.Higher alignment force appeared to have a higher likelihood of occurrence at tighter radii.Without further information or applicable imagery, a definitive root cause is unable to be determined at this time.However patient factors (tortuosity) and/or procedural factors (high alignment forces, valve alignment in a non-straight section) may have contributed to the reported event.No device or labeling problem was identified during the evaluation.Therefore, no further escalation ( capa/scar/pra) is required.Complaint histories for all reported events are reviewed against trending control limits monthly, and any excursions above the control limits are assessed and documented as part of this monthly review.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COMMANDER DELIVERY SYSTEM
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506385
MDR Report Key16258676
MDR Text Key308308107
Report Number2015691-2023-10421
Device Sequence Number1
Product Code NPT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/08/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/27/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/15/2024
Device Model Number9610TF29
Device Catalogue NumberN/A
Device Lot Number64284503
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received03/07/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/16/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-